Using Induced Pluripotent Stem Cells in Drug Discovery

iPSCs present a unique approach for modeling human physiology and disease and understanding the mechanism of action of a drug and its efficacy and safety. Our panel of experts will share their perspectives on the pros and cons of using iPSCs for research

By | August 8, 2014

iPSCs present a unique approach for modeling human physiology and disease and understanding the mechanism of action of a drug and its efficacy and safety. Our panel of experts will share their perspectives on the pros and cons of using iPSCs for research

Stem cells provide new opportunities for in vitro modeling and screening in a physiologically relevant environment that is consistent and replicable. Induced pluripotent stem cells (iPSCs), in particular, present a unique approach for modeling human physiology and disease and understanding the mechanism of action of a drug and its efficacy and safety. However, technical challenges remain to be overcome in culturing and maintaining iPSCs and people remain skeptical about the relevance and validity of the results obtained. Our panel of experts will share their perspectives on the pros and cons of using iPSCs for research and attendees can interact with the panel during the live webinar by asking questions and sharing their concerns.

Topics to be discussed include:

  • Induced pluripotent stem cells: potential uses and inherent limitations
  • Relevance of iPSCs as disease models
  • Case studies highlighting applications in efficacy and safe screening
  • Coupling gene editing and stem cell research

Meet the Speakers:

Dr. Steve Stice
Georgia Research Alliance Eminent Scholar
Endowed Chair
Professor and Director of the Regenerative Bioscience Center
The University of Georgia

 

Dr. Timothy J. Kamp
Professor of Medicine and Co-director
Stem Cell and Regenerative Medicine Center
University of Wisconsin–Madison School of Medicine and Public Health

 

Enzo
Life Technologies

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. Genetic Analysis Reveals the Evolutionary History of Dogs
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS